CancerIQ
PrivateLast Round
Debt
Aug 21, 2024
Total Funding Raised
$18.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CancerIQ operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Debt round in August 2024.
CancerIQ is a health technology company that provides a precision health platform for healthcare providers to identify, manage, and personalize care for patients at high risk for cancer.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, EHR & EMR, Patient Engagement, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CancerIQ Comparables
Compare CancerIQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lunit | 79% | |
| Azra AI | 79% | |
| MagView | 76% |
For institutional investors. Book with your work email.
CancerIQ Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Aug 21, 2024 | ||||
| Seed Round | Nov 1, 2023 | ||||
| Series B | Mar 3, 2022 | ||||
| Series A | Aug 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CancerIQ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lightbank | Series A |
| HealthX Ventures | Series B, Series A |
| Decathlon Capital Partners | Debt |
| McKesson Ventures | Series B |
| OSF Ventures | Series B |
| McKesson Ventures | Series B |
| The Impact Engine | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 106% MoM, reaching 26K.
- Jul 3, 2026
Serves over 60 enterprise customers.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 24, 2026
CancerIQ, Inc. announces two major updates to its Epic integrations in Illinois on Sep 24th '26, adding redesigned patient and provider experiences that support cancer screening, testing, surveillance, and follow-up from prevention through survivorship.
- integrates_withSep 24, 2026
CancerIQ, Inc. integrates with Epic Systems Corporation using FHIR R4 to draw clinical data directly from Epic Systems Corporation and consolidate risk assessment, testing, surveillance, and follow-up workflows into a unified EHR experience.
For institutional investors. Book with your work email.
CancerIQ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CancerIQ's valuation, stock price, and market status.
Is CancerIQ a public or private company?
CancerIQ is a private company.
What is the current stock price of CancerIQ?
CancerIQ is a private company, so its shares have no public market price. Caplight tracks CancerIQ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CancerIQ worth (valuation)?
Valuation information for CancerIQ is not publicly available.
Can I buy CancerIQ stock?
CancerIQ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CancerIQ's last funding round?
CancerIQ's most recent funding round was Debt on August 21, 2024.
Who are the main investors in CancerIQ?
Key investors in CancerIQ include HealthX Ventures, Decathlon Capital Partners, Amgen Ventures, Merck Capital Ventures.
Will CancerIQ IPO soon?
No public IPO plans have been announced for CancerIQ.
How can I track CancerIQ secondary market activity?
Caplight tracks bids, offers, and trades in CancerIQ's shares on secondary markets.